Peter Shaw is currently Global Vice President of Medical Affairs and Chief Medical Officer at Bioventus having spent the previous three years as Senior Medical Director in Medical Affairs at Ferring Pharmaceuticals where he was responsible for all US Orthopaedic and Specialty Products. Previously Peter was Chief Medical Officer at Emisphere Technologies and Q-Pharma. Peter received his medical training at the University of London, Charing Cross & Westminster Hospital Medical School and postgraduate medical education in Orthopaedics and General Surgery as well as OBGYN, General Medicine, Cardiology and Cardiopulmonary Transplant Medicine. He practiced in the United Kingdom for 23 years before entering the pharmaceutical industry and moving to the USA in 2006. While in clinical practice, Peter was post-graduate tutor in primary care and attending physician to a professional rugby club for 13 years.